Relaxin stimulates expression of vascular endothelial growth factor in normal human endometrial cells in vitro and is associated with menometrorrhagia in women.
about
Immunoexpression of the relaxin receptor LGR7 in breast and uterine tissues of humans and primatesBiology of primate relaxin: a paracrine signal in early pregnancy?Serelaxin for the treatment of acute heart failure: a review with a focus on end-organ protectionG-Protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin/insulin-like family peptide receptor 1 for treatment and preventionRelaxin stimulates multiple signaling pathways: activation of cAMP, PI3K, and PKCzeta in THP-1 cells.Circulating levels of matrix proteases and their inhibitors in pregnant women with and without a history of recurrent pregnancy lossRelaxin regulates MMP expression and promotes satellite cell mobilization during muscle healing in both young and aged mice.Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1.Angiogenic growth factors are new and essential players in the sustained relaxin vasodilatory pathway in rodents and humansRelaxin induces rapid dilation of rodent small renal and human subcutaneous arteries via PI3 kinase and nitric oxide.Primate preimplantation embryo is a target for relaxin during early pregnancyInternational Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.New Drugs You Are Going to Read About: Serelaxin, Ularitide, TRV027.Constitutive formation of an RXFP1-signalosome: a novel paradigm in GPCR function and regulation.Emerging role of relaxin in the maternal adaptations to normal pregnancy: implications for preeclampsiaNew insight into the transcriptional regulation of vascular endothelial growth factor expression in the endometrium by estrogen and relaxin.Heterogeneity of the afferent arteriole--correlations between morphology and function.Relaxin deficiency results in increased expression of angiogenesis- and remodelling-related genes in the uterus of early pregnant mice but does not affect endometrial angiogenesis prior to implantationRelaxin as a natural agent for vascular healthRecombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial.Relaxin, its receptor (RXFP1), and insulin-like peptide 4 expression through gestation and in placenta accreta.Vasodilators in the treatment of acute heart failure: what we know, what we don't.Relaxin, a pleiotropic vasodilator for the treatment of heart failure.Relaxin regulation of endometrial structure and function in the rhesus monkeyRelaxin improves multiple markers of wound healing and ameliorates the disturbed healing pattern of genetically diabetic mice.Recombinant human relaxin-2: (how) can a pregnancy hormone save lives in acute heart failure?Serelaxin in clinical development: past, present and future.Serelaxin for the treatment of heart failure.Synthetic non-peptide low molecular weight agonists of the relaxin receptor 1.The Role of Relaxin in Normal and Abnormal Uterine Function During the Menstrual Cycle and Early Pregnancy.Relaxin' the Heart: A Novel Therapeutic Modality.Relaxin pretreatment decreases infarct size in male rats after middle cerebral artery occlusion.Regulation and role of vascular endothelial growth factor in the corpus luteum during mid-pregnancy in rats.Relaxin activates the MAP kinase pathway in human endometrial stromal cells.Relaxin signalling in primary cultures of human myometrial cells.Implantation and pregnancy following in vitro fertilization and the effect of recombinant human relaxin administration in Macaca fascicularis.Human relaxins (RLNH1, RLNH2), their receptor (RXFP1) and fetoplacental growth.Luteal and hypophyseal expression of the canine relaxin (RLN) system during pregnancy: Implications for luteotropic function.Prolonged RXFP1 and RXFP2 signaling can be explained by poor internalization and a lack of beta-arrestin recruitment.Photonic monitoring in real time of vascular endothelial growth factor receptor 2 gene expression under relaxin-induced conditions in a novel murine wound model.
P2860
Q21093262-C8C6A255-73D1-4626-9B49-15D813B50717Q24802524-66AEFFE9-F7C5-49E1-9974-7961D400A477Q26740185-4D856EE8-6EB0-4906-BA7B-E27F121F7E10Q26744192-3EA87F50-EDF3-494C-8E0A-37CC275E6DABQ33757389-D6B10C0D-8255-4FD7-8594-C9045F65C6CAQ33981235-9FAE59B3-A248-43D6-B590-C68FAB58DEB9Q34254473-B1940272-945B-40BF-B129-0A22972EBDB3Q34771756-80B641F0-B50C-42EB-AB36-4E044E1A0D5BQ35042471-3C4A8782-D8C0-4338-B2C1-6BB0C1DF6404Q35046881-28D6377E-6F69-4D32-83A7-25B91C7A2FC1Q35085649-4CBD3AAC-4E7F-4647-B890-B6A40C98EC13Q35383835-1920B0B2-F8DA-4F39-ABB4-517198EACD77Q35899860-5CDEC7F7-5E0E-4933-8B4A-2AD3FBA72E1EQ36025314-35A65DB8-51EA-4238-BE41-349AD22E181BQ36054390-7B48B290-9C32-451E-9962-436499434BA7Q36163304-EB0BF2C4-9EAA-40B8-B0E1-45CCD16AFEBEQ36541230-A524AD14-DC09-46C0-B31B-CF9AA541F332Q36715081-F5F0AD11-4AA8-48CD-B99A-87BEDA78F4F5Q36835818-63170742-52AD-4D7C-8860-558B27F4E702Q37013037-C88CB580-6EC3-4A4D-A9E2-BBC9037D4302Q37019967-88C33497-6A4C-42B7-8271-3FE28B4B7346Q37355110-9167AF23-03C2-4878-8D27-782DAA3418A1Q37356318-0F0ECCE0-0B8F-4FBE-94BF-40E78528E1A1Q37358514-D4052C8E-8872-4DFF-A6DB-8E95B9E9F176Q37532442-E7533B41-24DF-40E2-A6D5-06F5D4206F8CQ38220684-E648AD1B-2F07-4F48-8BCB-D741DAAA6452Q38778886-B6734C58-0DA4-440A-B183-44B451A5F6BAQ38798476-44586EDC-B27E-48C9-B4EE-ED4388108FA9Q38807047-2BA7A723-B9D8-4C16-AC53-545244659900Q38882840-8C02554F-180B-4672-91FB-2CDB987F89C1Q38940630-55FBBD09-8670-4A26-A5F1-76B23B64076EQ39720492-1E1ED941-B717-4FCE-A2DD-54CEF62E161FQ43513891-523CDCB0-F988-49E4-9578-4493593B5041Q46078497-65242CE2-3904-4408-8EAE-5380B48A54ABQ46355454-999D5135-B984-4234-BE9B-B0ADC9542329Q47233606-8C82BDF3-8B87-44FF-A6EC-6A9277632825Q47774900-09029AFB-A270-4A97-8F21-CBB98AF8AAFDQ48174089-2658B4F5-6230-436A-B1AA-15196C787474Q50600080-6E0850D5-7FC3-4CB7-B9E3-B7780E97DA80Q51222277-3B5EBE89-36B0-4619-BEDA-51DA1909462F
P2860
Relaxin stimulates expression of vascular endothelial growth factor in normal human endometrial cells in vitro and is associated with menometrorrhagia in women.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Relaxin stimulates expression ...... ith menometrorrhagia in women.
@en
type
label
Relaxin stimulates expression ...... ith menometrorrhagia in women.
@en
prefLabel
Relaxin stimulates expression ...... ith menometrorrhagia in women.
@en
P2093
P356
P1433
P1476
Relaxin stimulates expression ...... ith menometrorrhagia in women.
@en
P2093
Erikson ME
Parsell DA
Sutherland KM
Unemori EN
P304
P356
10.1093/HUMREP/14.3.800
P407
P577
1999-03-01T00:00:00Z